Innovage Holding Corp.

The current price of INNV is $9.08 — it has decreased by 0.07% since the previous close. Data as of Nov 6, 2026.

INNV is down 1.52% over the past week, up 1.00% over the past month and up 86.27% over the past year. The price is below its 200-day moving average of $9.13.

Analysts' average 12-month price target for INNV is $14.00, which implies 54.13% upside from the current price. Individual estimates range from $14.00 to $14.00.

Of the 3 analysts covering Innovage Holding Corp., 1 rates it a buy, 1 rates it a hold and 1 rates it a strong sell. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.

Innovage Holding Corp. has a market capitalization of $1.24B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, Innovage Holding Corp. posted earnings of $0.14 per share against an estimate of $0.08594, beating expectations by 62.90%. Upcoming reports are listed in the earnings calendar.

Innovage Holding Corp. reported revenue of $264.76M in its most recent quarter, which has increased by 12.14% compared with the same quarter a year earlier. Analysts had expected $257.23M.

Innovage Holding Corp. has not paid any dividends over the past year.

In the latest trading session INNV moved between $8.87 and $9.29, a range of 4.57% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Innovage Holding Corp. shows a sell rating today and a neutral rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Innovage Holding Corp. is buy. Technical ratings are indicators, not investment advice.

Over the past 52 weeks INNV has traded between $4.53 and $12.64. The current price is 28.14% below its 52-week high.